E-DRUG: Why it is a good idea to extend the LDC medicines transition at the WTO
----------------------------------------------------------------------------------------------------------
Dear e-drug readers,
Please find here the link to a brief piece I did for IP-watch on why it is a good idea to extend the transition period for the implementation of the WTO TRIPS obligations with regards to medicines patents and the protection of undisclosed data.
Kind regards,
Ellen